Ocugen appoints new acting chief medical officer

Ocugen Inc. (NASDAQ: OCGN) announced leadership changes in its medical department. Huma Qamar, M.D., MPH, CMI, separated from the company as Chief Medical Officer effective May 8, 2026.

The company appointed Mohamed Genead, M.D., M.Sc., as Acting/Interim Chief Medical Officer on the same date, according to the company's filing.

You May Also Be Interested In

• Circle board member resigns after nearly 13 years of service
• Nutrien warns shareholders about below-market mini-tender offer
• M3-Brigade cancels shareholder meeting after terminating ReserveOne deal